CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 69 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q4 2020. The put-call ratio across all filers is 57.45 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $346,000 | 0.0% | 18,844 | 0.0% | 0.00% | -100.0% |
| Q3 2020 | $346,000 | +22.7% | 18,844 | 0.0% | 0.00% | – |
| Q2 2020 | $282,000 | -5.4% | 18,844 | 0.0% | 0.00% | -100.0% |
| Q1 2020 | $298,000 | -1.7% | 18,844 | +1.2% | 0.00% | 0.0% |
| Q4 2019 | $303,000 | +9.4% | 18,629 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $277,000 | -10.1% | 18,629 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $308,000 | -1.9% | 18,629 | +2.5% | 0.00% | 0.0% |
| Q1 2019 | $314,000 | -2.2% | 18,173 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $321,000 | -0.3% | 18,173 | +2.3% | 0.00% | 0.0% |
| Q3 2018 | $322,000 | -7.2% | 17,757 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $347,000 | +20.1% | 17,757 | -27.5% | 0.00% | 0.0% |
| Q1 2017 | $289,000 | -11.6% | 24,498 | -2.0% | 0.00% | 0.0% |
| Q4 2016 | $327,000 | -12.6% | 24,998 | -3.1% | 0.00% | 0.0% |
| Q3 2016 | $374,000 | +22.2% | 25,798 | +1.2% | 0.00% | 0.0% |
| Q2 2016 | $306,000 | -21.3% | 25,498 | +22.3% | 0.00% | 0.0% |
| Q1 2016 | $389,000 | -1.0% | 20,854 | +14.1% | 0.00% | 0.0% |
| Q4 2015 | $393,000 | +29.7% | 18,270 | +2.2% | 0.00% | 0.0% |
| Q3 2015 | $303,000 | -55.0% | 17,870 | -0.6% | 0.00% | -50.0% |
| Q2 2015 | $674,000 | – | 17,970 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|